Tags

Type your tag names separated by a space and hit enter

Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.
Oncology. 2008; 74(1-2):50-60.O

Abstract

BACKGROUND/AIMS

CpG island (CGI) methylator phenotype (CIMP) is strongly associated with poor prognosis in neuroblastomas (NBLs; hazard ratios 7-22). Methylation of nonpromoter CGIs is useful to detect the presence of the CIMP, while the poor prognosis is considered to be caused by gene silencing due to promoter methylation. Here, promoter CGIs targeted by the CIMP were searched for.

METHODS

A genome-wide screening was performed by methylation-sensitive representational difference analysis of CIMP(+) and CIMP(-) NBLs.

RESULTS

Promoter CGIs of 9 genes were methylated in CIMP(+) NBL cell lines and caused silencing of their downstream genes. On analysis of 90 clinical specimens, CYP26C1,FERD3L (N-TWIST), CRYBA2 and PCDHGC4 were methylated at significantly higher incidences in CIMP(+) NBLs than CIMP(-) NBLs, while the difference was unclear for NPY, SPAG6, DDIT4L, CHR3SYT and C6Orf141. Methylation of CYP26C1 and FERD3L was significantly associated with poor prognosis, but weaker than the presence of the CIMP. Treatment of an NBL cell line with a demethylating agent caused demethylation of multiple promoter CGIs, and enhanced 13-cis-retinoic acid-induced neuronal differentiation.

CONCLUSION

Our results indicate that the CIMP causes poor prognosis of NBLs by inducing methylation of multiple promoter CGIs with various incidences.

Authors+Show Affiliations

Carcinogenesis Division, National Cancer Center Research Institute, Tokyo, Japan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18544995

Citation

Abe, Masanobu, et al. "Identification of Genes Targeted By CpG Island Methylator Phenotype in Neuroblastomas, and Their Possible Integrative Involvement in Poor Prognosis." Oncology, vol. 74, no. 1-2, 2008, pp. 50-60.
Abe M, Watanabe N, McDonell N, et al. Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis. Oncology. 2008;74(1-2):50-60.
Abe, M., Watanabe, N., McDonell, N., Takato, T., Ohira, M., Nakagawara, A., & Ushijima, T. (2008). Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis. Oncology, 74(1-2), 50-60. https://doi.org/10.1159/000139124
Abe M, et al. Identification of Genes Targeted By CpG Island Methylator Phenotype in Neuroblastomas, and Their Possible Integrative Involvement in Poor Prognosis. Oncology. 2008;74(1-2):50-60. PubMed PMID: 18544995.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis. AU - Abe,Masanobu, AU - Watanabe,Naoko, AU - McDonell,Nathalie, AU - Takato,Tsuyoshi, AU - Ohira,Miki, AU - Nakagawara,Akira, AU - Ushijima,Toshikazu, Y1 - 2008/06/11/ PY - 2007/11/16/received PY - 2008/01/17/accepted PY - 2008/6/12/pubmed PY - 2008/7/23/medline PY - 2008/6/12/entrez SP - 50 EP - 60 JF - Oncology JO - Oncology VL - 74 IS - 1-2 N2 - BACKGROUND/AIMS: CpG island (CGI) methylator phenotype (CIMP) is strongly associated with poor prognosis in neuroblastomas (NBLs; hazard ratios 7-22). Methylation of nonpromoter CGIs is useful to detect the presence of the CIMP, while the poor prognosis is considered to be caused by gene silencing due to promoter methylation. Here, promoter CGIs targeted by the CIMP were searched for. METHODS: A genome-wide screening was performed by methylation-sensitive representational difference analysis of CIMP(+) and CIMP(-) NBLs. RESULTS: Promoter CGIs of 9 genes were methylated in CIMP(+) NBL cell lines and caused silencing of their downstream genes. On analysis of 90 clinical specimens, CYP26C1,FERD3L (N-TWIST), CRYBA2 and PCDHGC4 were methylated at significantly higher incidences in CIMP(+) NBLs than CIMP(-) NBLs, while the difference was unclear for NPY, SPAG6, DDIT4L, CHR3SYT and C6Orf141. Methylation of CYP26C1 and FERD3L was significantly associated with poor prognosis, but weaker than the presence of the CIMP. Treatment of an NBL cell line with a demethylating agent caused demethylation of multiple promoter CGIs, and enhanced 13-cis-retinoic acid-induced neuronal differentiation. CONCLUSION: Our results indicate that the CIMP causes poor prognosis of NBLs by inducing methylation of multiple promoter CGIs with various incidences. SN - 1423-0232 UR - https://www.unboundmedicine.com/medline/citation/18544995/Identification_of_genes_targeted_by_CpG_island_methylator_phenotype_in_neuroblastomas_and_their_possible_integrative_involvement_in_poor_prognosis_ L2 - https://www.karger.com?DOI=10.1159/000139124 DB - PRIME DP - Unbound Medicine ER -